PRPH Competitors & Alternatives
Compare ProPhase Labs Inc with similar stocks in the same industry
Diagnostics & Research
PRPH
Main Stock$0.36
Tradestie Score
40
Market Cap
$21.41M
Revenue Growth
-0.4%
Analyst Upside
+3705.8%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$17.38
|
$1.13B | - | 43 | Compare |
|
CDNA
CareDx, Inc.
|
$50.88
|
$798.40M | 24.0 | 35 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$19.73
|
$719.31M | - | 54 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$32.91
|
$667.77M | - | 39 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$17.20
|
$612.76M | - | 37 | Compare |
|
ICCC
Immucell Corp
|
$9.90
|
$59.70M | 142.9 | 63 | Compare |
|
CPIX
Cumberland Pharmaceuticals Inc
|
$6.79
|
$46.68M | - | 56 | Compare |
|
NAII
Natural Alternatives International Inc.
|
$2.08
|
$17.91M | - | 52 | Compare |
|
XTLB
XTL Biopharmaceuticals Ltd. American Depositary Shares
|
$2.53
|
$10.14M | - | 55 | Compare |
|
SNOA
Sonoma Pharmaceuticals, Inc. Common Stock
|
$1.33
|
$6.37M | - | 59 | Compare |
More PRPH Analysis
Data updated: Sep 04, 2026 | Industry: Diagnostics & Research (SIC 2834)
39 stocks in this industry